Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

Patients who received preoperative semaglutide (Ozempic, Wegovy) for 24.4 weeks lost a median of ... controls prior to ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

The results of a planned interim analysis conducted at week 72 ... 10.5% with semaglutide and −2.0% with placebo (estimated difference, −8.5 percentage points; 95% CI, −9.6 to −7.4 ...